Telo Genomics Management
Management criteria checks 4/4
Telo Genomics' CEO is Sabine Mai, appointed in Dec 2023, has a tenure of less than a year. total yearly compensation is CA$30.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 3.77% of the company’s shares, worth $219.77K. The average tenure of the management team and the board of directors is 3.6 years and 4.8 years respectively.
Key information
Sabine Mai
Chief executive officer
CA$30.0k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | less than a year |
| CEO ownership | 3.8% |
| Management average tenure | 3.6yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | CA$30k | CA$30k | -CA$3m |
| Mar 31 2024 | n/a | n/a | -CA$3m |
| Dec 31 2023 | n/a | n/a | -CA$3m |
| Sep 30 2023 | n/a | n/a | -CA$3m |
| Jun 30 2023 | CA$30k | n/a | -CA$3m |
| Mar 31 2023 | n/a | n/a | -CA$3m |
| Dec 31 2022 | n/a | n/a | -CA$2m |
| Sep 30 2022 | n/a | n/a | -CA$2m |
| Jun 30 2022 | CA$30k | n/a | -CA$2m |
| Mar 31 2022 | n/a | n/a | -CA$2m |
| Dec 31 2021 | n/a | n/a | -CA$2m |
| Sep 30 2021 | n/a | n/a | -CA$1m |
| Jun 30 2021 | CA$24k | n/a | -CA$1m |
| Mar 31 2021 | n/a | n/a | -CA$1m |
| Dec 31 2020 | n/a | n/a | -CA$953k |
| Sep 30 2020 | n/a | n/a | -CA$1m |
| Jun 30 2020 | CA$20k | n/a | -CA$1m |
| Mar 31 2020 | n/a | n/a | -CA$1m |
| Dec 31 2019 | n/a | n/a | -CA$1m |
| Sep 30 2019 | n/a | n/a | -CA$634k |
| Jun 30 2019 | CA$30k | n/a | -CA$1m |
| Dec 31 2018 | n/a | n/a | -CA$3m |
| Sep 30 2018 | n/a | n/a | -CA$4m |
| Jun 30 2018 | CA$16k | n/a | -CA$5m |
Compensation vs Market: Sabine's total compensation ($USD21.33K) is below average for companies of similar size in the US market ($USD647.72K).
Compensation vs Earnings: Sabine's compensation has been consistent with company performance over the past year.
CEO
Sabine Mai
less than a year
Tenure
CA$30,000
Compensation
Dr. Sabine Mai, Ph. D. is Interim Chief Executive Officer at Telo Genomics Corp since December 08, 2023. She is Chair of Clinical & Scientific Advisory Board at Telo Genomics Corp. (formerly known as 3D Si...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | less than a year | CA$30.00k | 3.77% $ 219.8k | |
| President & CTO | 6.2yrs | CA$167.37k | no data | |
| Chief Financial Officer | 3.6yrs | CA$60.00k | no data |
3.6yrs
Average Tenure
Experienced Management: TDSG.F's management team is considered experienced (3.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 8.2yrs | CA$30.00k | 3.77% $ 219.8k | |
| Member of Clinical & Scientific Advisory Board | 8yrs | no data | no data | |
| Independent Director | 4.8yrs | CA$18.00k | 0.040% $ 2.3k | |
| Independent Director | 2.8yrs | CA$40.83k | no data | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Chairman of the Board | 5.8yrs | CA$81.67k | no data | |
| Member of Clinical Advisory Board | less than a year | no data | no data | |
| Member of Clinical Advisory Board | less than a year | no data | no data | |
| Independent Director | 6.2yrs | no data | 1.42% $ 83.1k | |
| Member of Clinical Advisory Board | less than a year | no data | no data | |
| Member of Clinical & Scientific Advisory Board | 8yrs | no data | no data | |
| Member of Clinical Advisory Board | less than a year | no data | no data |
4.8yrs
Average Tenure
59yo
Average Age
Experienced Board: TDSG.F's board of directors are considered experienced (4.8 years average tenure).